MARKET

NSPR

NSPR

INSPIREMD
AMEX

Real-time Quotes | Nasdaq Last Sale

0.8765
-0.0723
-7.62%
After Hours: 0.8700 -0.0065 -0.74% 17:53 11/15 EST
OPEN
0.9300
PREV CLOSE
0.9488
HIGH
0.9511
LOW
0.8600
VOLUME
117.67K
TURNOVER
--
52 WEEK HIGH
11.99
52 WEEK LOW
0.8600
MARKET CAP
1.70M
P/E (TTM)
-0.0829
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NSPR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NSPR News

  • Is InspireMD, Inc. (NYSEMKT:NSPR) A Volatile Stock?
  • Simply Wall St..2d ago
  • InspireMD, Inc. (NSPR) CEO Jim Barry on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.3d ago
  • InspireMD (NSPR) Investor Presentation - Slideshow
  • Seeking Alpha - Article.3d ago
  • InspireMD, Inc. Common Stock Q3 EPS $(1.26) Beats $(1.35) Estimate, Sales $939K Miss $1.4M Estimate
  • Benzinga.3d ago

More

Industry

Medical Equipment, Supplies & Distribution
+1.46%
Healthcare Equipment & Supplies
+1.93%

Hot Stocks

Name
Price
%Change

About NSPR

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
More

Webull offers InspireMD Inc (NSPR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.